Press release
Pulmonary Drug Delivery Devices Market Size Forecasted To Achieve $69.91 Billion By 2029 With Steady Growth
Pulmonary Drug Delivery Devices
What Is the Pulmonary Drug Delivery Devices Market Size and Projected Growth Rate?
The pulmonary drug delivery devices market has experienced strong growth in recent years. It will rise from $49.52 billion in 2024 to $53.21 billion in 2025 at a CAGR of 7.4%. This growth can be attributed to the increasing prevalence of respiratory diseases such as COPD, asthma, and cystic fibrosis, the global aging population, heightened awareness of respiratory health, increased healthcare spending in emerging economies, and the growing use of homecare settings for respiratory therapy.
The pulmonary drug delivery devices market is projected to grow to $69.91 billion by 2029 at a CAGR of 7.1%. Growth factors include rising demand for personalized and precision respiratory care, the expansion of home healthcare and remote monitoring services, increased research investments, and a focus on preventive healthcare. Trends to watch include technological innovations, the adoption of value-based care models, integration of telehealth in respiratory care, the use of wearables for condition self-management, and the application of 3D printing and digital manufacturing in therapy development.
Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15907
What Are the Major Segments in the Pulmonary Drug Delivery Devices Market?
The pulmonary drug delivery devices market covered in this report is segmented -
1) By Product Type: Dry Powder Inhalers, Metered Dose Inhalers, Nebulizers
2) By Application: Asthma, Cystic Fibrosis, Chronic Obstructive Pulmonary Disease, Other Applications
3) By Distribution Channel: Retail Pharmacies, Hospital Pharmacies, E-Commerce
Subsegments:
1) By Dry Powder Inhalers (DPIs): Single-Dose DPIs, Multi-Dose DPIs
2) By Metered Dose Inhalers (MDIs): CFC-Based MDIs, HFA-Based MDIs
3) By Nebulizers: Jet Nebulizers, Ultrasonic Nebulizers, Mesh Nebulizers
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15907&type=smp
What Are The Driving Pulmonary Drug Delivery Devices Market Evolution?
The increasing prevalence of respiratory disorders is anticipated to drive growth in the pulmonary drug delivery devices market. Respiratory disorders impact lung and airway functions and are becoming more common due to factors like air pollution, smoking, aging populations, and urbanization. Pulmonary drug delivery devices are essential in treating these disorders by directly administering medications to the lungs. For example, in May 2024, the CDC reported a rise in asthma cases among U.S. adults, from 8.0% in 2021 to 8.7% in 2022. This growth in respiratory diseases is expected to propel the pulmonary drug delivery devices market.
Which Firms Dominate The Pulmonary Drug Delivery Devices Market Segments?
Major companies operating in the pulmonary drug delivery devices market are Medtronic plc, Air Liquide S.A., Becton Dickinson and Company, Koninklijke Philips N.V., Medline Industries Inc., ResMed Inc., Drägerwerk AG And Co. KGaA, Smiths Group plc, AptarGroup Inc., Chiesi Farmaceutici S.p.A., Teleflex Incorporated, Masimo Corporation, Fisher And Paykel Healthcare Limited, Invacare Corporation, Vyaire Medical Inc., Inogen Inc., Drive DeVilbiss Healthcare Inc., Hovione, Hamilton Medical AG, GaleMed Corporation, Allied Healthcare Products Inc., Precision Medical Inc., Salter Labs Inc., Nidek Medical Products Inc.
What Trends Are Expected to Dominate the Pulmonary Drug Delivery Devices Market in the Next 5 Years?
Companies in the pulmonary drug delivery devices market are focusing on creating advanced products, such as small-volume nebulizers, to enhance customer service with additional features. Small-volume nebulizers (SVNs) deliver liquid medication as an aerosol mist to patients with respiratory issues like asthma, COPD, or cystic fibrosis. For instance, in May 2024, Medline Industries launched the Hudson RCI TurboMist nebulizer, designed to provide faster treatment in as little as three minutes. This nebulizer can deliver 2.5 times more medication per minute compared to standard nebulizers, reducing treatment time by about 70%, improving healthcare providers' efficiency and patient satisfaction.
Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/pulmonary-drug-delivery-devices-global-market-report
Which Is The Largest Region In The Pulmonary Drug Delivery Devices Market?
North America was the largest region in the pulmonary drug delivery devices market in 2023. The regions covered in the pulmonary drug delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Pulmonary Drug Delivery Devices Market?
2. What is the CAGR expected in the Pulmonary Drug Delivery Devices Market?
3. What Are the Key Innovations Transforming the Pulmonary Drug Delivery Devices Industry?
4. Which Region Is Leading the Pulmonary Drug Delivery Devices Market?
Why This Report Matters:
Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.
Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.
Efficient Research: Quickly identify market growth, leading players, and major segments.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Pulmonary Drug Delivery Devices Market Size Forecasted To Achieve $69.91 Billion By 2029 With Steady Growth here
News-ID: 4044765 • Views: …
More Releases from The Business Research Company
Surging Application Across End Users Powers the Expansion of the Thermosetting A …
What Is the Projected Size of the Thermosetting Acrylic Adhesive Market by 2025?
The market for thermosetting acrylic adhesives has experienced robust expansion recently, projecting an increase from $1.16 billion in 2024 to $1.24 billion in 2025, reflecting a compound annual growth rate of 6.7%; this upswing during the past period stems from heightened requirements within the automotive sector, greater incorporation in building projects, escalating uptake in the creation of electronic…
Consistent Growth Projected for Temporary Floor Protection Market, Reaching $2 B …
How Much Is the Temporary Floor Protection Market Expected to Expand by 2025?
The temporary floor protection sector has experienced robust expansion lately, projected to elevate its market valuation from 1.41 billion USD in 2024 to 1.52 billion USD by 2025, reflecting a compound annual growth rate of 7.6 percent; this earlier period's upward trend stems from a surge in building undertakings, an upward trend in refurbishment assignments, escalating requirements within…
Accelerated Digital Transformation Fuels Expansion in the Talent Marketplace For …
What Is the Projected Size of the Talent Marketplace For Creators Market by 2025?
The sphere of the creator talent marketplace is characterized by swift expansion recently, projected to climb from a valuation of $9.65 billion in 2024 to $11.47 billion in 2025, reflecting a compound annual growth rate (CAGR) of 18.9%; this past growth trajectory has been fueled by several factors, including escalated needs for digital media output, a broadening…
2025-2034 Swimming Pool Circulation Systems Market Evolution: Emerging Opportuni …
How Much Is the Swimming Pool Circulation Systems Market Expected to Expand by 2025?
The overall scale of the swimming pool circulation systems market has experienced substantial expansion over the past few years, projecting an increase from its 2024 valuation of $4.79 billion to $5.12 billion in 2025, reflecting a steady compound annual growth rate (CAGR) of seven percent. This upward trajectory observed during the historical period is largely driven by…
More Releases for Pulmonary
Innovation In Pulmonary Drug Delivery Devices Industry Trends Gaining Momentum i …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Pulmonary Drug Delivery Devices Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market size for pulmonary drug delivery devices has experienced significant growth in the past few years. The market is projected to increase from $49.52 billion in 2024 to $52.8 billion in 2025,…
Chronic Pulmonary Aspergillosis Drugs Market - Revitalizing Lungs: Revolutionary …
Newark, New Castle, USA - new report, titled Chronic Pulmonary Aspergillosis Drugs Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Chronic Pulmonary Aspergillosis Drugs market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Chronic Pulmonary Aspergillosis Drugs market. The report offers…
Global Pulmonary Arterial Hypertension Market Size
According to a new market research report published by Global Market Estimates, the Global Pulmonary Arterial Hypertension Market is projected to grow at a CAGR of 5.2% from 2022 to 2027.
Congenital heart diseases and other ailments such as HIV infection, chronic liver disease (cirrhosis), and connective tissue disorders (scleroderma, lupus, and others) are fueling market expansion.
Browse 153 Market Data Tables and 113 Figures spread through 185 Pages and in-depth TOC…
New Study: Pulmonary Drugs Market Report
The pulmonary drugs market is expected to witness unprecedented growth in the near future, thanks to large number of approvals from the FDA. The FDA approved a large number of pulmonary drugs for major illnesses like small-cell lung cancer, tuberculosis, and pneumonia over the past few years. Additionally, newly approved drugs also treat newly found diseases like obstructive sleep apnea. These approvals are in line with the recent trend of…
Pulmonary Drugs Market Forecast till 2025
Pulmonary Drugs Market – Boon for Diseased Lungs
Pulmonary drugs can treat wide range of conditions, which are included within the ambit of pulmonary diseases such as pneumonia, allergic rhinitis, pulmonary hypertension, and others. . Pulmonary drugs provide medications for all types of pulmonary diseases, which is expected to fuel market growth in near future. The World Health Organization (WHO) states that most respiratory diseases are preventable and can be treated…
Pulmonary Drug Delivery Devices Market: Demand for Pulmonary Drug Delivery Devic …
This report on pulmonary drug delivery devices studies the current as well as future prospects of the market globally. The stakeholders of this report include companies and intermediaries engaged in the manufacture and commercialization of various pulmonary/respiratory drugs and/or drug-device combinations as well as new entrants planning to enter this market.
This report comprises an elaborate executive summary along with a market snapshot providing overall information of various segments and sub-segments…
